← Eichor
Study identifier: NCT06317441 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Related Gastrointestinal Symptoms

Condition: Small Intestinal Bacterial Overgrowth · SIBO  ·  Sponsor: Nimble Science Ltd.

PhaseNA
Planned participants105
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The goal of this study is to test the effect of a probiotic formulation on gastrointestinal symptoms, gut and small intestine microbiota in participants suffering from small intestinal bacterial overgrowth (SIBO). Two doses of probiotic will be evaluated against placebo.

This description comes directly from the study's public registry record.

Talk to the study team

Gwen Duytschaever, PhD  ·  8664934633  ·  clinical@nimblesci.com

Isaac Wong, MBT  ·  8664934633  ·  clinical@nimblesci.com

Always discuss trial participation with your own doctor first.

Locations (1)

Nimble ScienceCalgary, Alberta, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06317441